BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 37922108)

  • 1. Functional Roles of CD133: More than Stemness Associated Factor Regulated by the Microenvironment.
    Moreno-Londoño AP; Robles-Flores M
    Stem Cell Rev Rep; 2024 Jan; 20(1):25-51. PubMed ID: 37922108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological β-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma.
    Cheng Y; Cheung AK; Ko JM; Phoon YP; Chiu PM; Lo PH; Waterman ML; Lung ML
    BMC Cell Biol; 2013 Sep; 14():44. PubMed ID: 24073846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
    Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
    Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A GLIS3-CD133-WNT-signaling axis regulates the self-renewal of adult murine pancreatic progenitor-like cells in colonies and organoids.
    Tremblay JR; Lopez K; Ku HT
    J Biol Chem; 2019 Nov; 294(45):16634-16649. PubMed ID: 31533988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. R-spondin1/Wnt-enhanced Ascl2 autoregulation controls the self-renewal of colorectal cancer progenitor cells.
    Ye J; Liu S; Shang Y; Chen H; Wang R
    Cell Cycle; 2018; 17(8):1014-1025. PubMed ID: 29886802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.
    Soeda A; Park M; Lee D; Mintz A; Androutsellis-Theotokis A; McKay RD; Engh J; Iwama T; Kunisada T; Kassam AB; Pollack IF; Park DM
    Oncogene; 2009 Nov; 28(45):3949-59. PubMed ID: 19718046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging roles of prominin-1 (CD133) in the dynamics of plasma membrane architecture and cell signaling pathways in health and disease.
    Pleskač P; Fargeas CA; Veselska R; Corbeil D; Skoda J
    Cell Mol Biol Lett; 2024 Mar; 29(1):41. PubMed ID: 38532366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New emerging roles of CD133 in cancer stem cell: Signaling pathway and miRNA regulation.
    Aghajani M; Mansoori B; Mohammadi A; Asadzadeh Z; Baradaran B
    J Cell Physiol; 2019 Dec; 234(12):21642-21661. PubMed ID: 31102292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLI1 promotes cancer stemness through intracellular signaling pathway PI3K/Akt/NFκB in colorectal adenocarcinoma.
    Yang Z; Zhang C; Qi W; Cui Y; Xuan Y
    Exp Cell Res; 2018 Dec; 373(1-2):145-154. PubMed ID: 30321514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway.
    Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ
    Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX2 and p53 Expression Control Converges in PI3K/AKT Signaling with Versatile Implications for Stemness and Cancer.
    Schaefer T; Steiner R; Lengerke C
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The expression and function of PD-L1 in CD133(+) human liver cancer stem-like cells].
    Bai YD; Shi ML; Li SQ; Wang XL; Peng JJ; Zhou DJ; Sun FF; Li H; Wang C; Du M; Zhang T; Li D
    Zhonghua Zhong Liu Za Zhi; 2023 Feb; 45(2):117-128. PubMed ID: 36781232
    [No Abstract]   [Full Text] [Related]  

  • 13. IGF2 induces CD133 expression in esophageal cancer cells to promote cancer stemness.
    Xu WW; Li B; Zhao JF; Yang JG; Li JQ; Tsao SW; He QY; Cheung ALM
    Cancer Lett; 2018 Jul; 425():88-100. PubMed ID: 29604392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
    Tang Y; Berlind J; Mavila N
    Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Notch1 and IKKα Enhanced NF-κB Activation in CD133
    Quan XX; Hawk NV; Chen W; Coupar J; Lee SK; Petersen DW; Meltzer PS; Montemarano A; Braun M; Chen Z; Van Waes C
    Mol Cancer Ther; 2018 Sep; 17(9):2034-2048. PubMed ID: 29959199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3β/β-catenin signaling required for maintenance of cancer stem cell properties.
    Su YJ; Lin WH; Chang YW; Wei KC; Liang CL; Chen SC; Lee JL
    Oncotarget; 2015 Nov; 6(35):38029-45. PubMed ID: 26515729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midkine downregulation increases the efficacy of quercetin on prostate cancer stem cell survival and migration through PI3K/AKT and MAPK/ERK pathway.
    Erdogan S; Turkekul K; Dibirdik I; Doganlar O; Doganlar ZB; Bilir A; Oktem G
    Biomed Pharmacother; 2018 Nov; 107():793-805. PubMed ID: 30142541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-independent androgen receptors promote ovarian teratocarcinoma cell growth by stimulating self-renewal of cancer stem/progenitor cells.
    Chung WM; Chang WC; Chen L; Lin TY; Chen LC; Hung YC; Ma WL
    Stem Cell Res; 2014 Jul; 13(1):24-35. PubMed ID: 24793306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NOP14 nucleolar protein suppresses the function and stemness of melanoma stem-like cells through Wnt/beta-catenin signaling inactivation.
    Li J; Fang R; Wu J; Si Y; Bai J; Wang Q
    Bioengineered; 2022 Mar; 13(3):7648-7658. PubMed ID: 35282769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
    Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
    J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.